Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids

Abstract

GANT61 significantly suppressed Hedgehog signaling to reverse sorafenib resistance in CD44-positive HCC. The combination of sorafenib and Hedgehog signaling inhibitors might be effective in HCC patients with high CD44 levels as a personalized-medicine approach.